| Year |
Citation |
Score |
| 2019 |
Raza A, Pandey MS, Jin Q, Mulder KM. Role of km23-1 in Ras/ERK regulationkm23-1/DYNLRB1 regulation of MEK/ERK signaling and R-Ras in invasive human colorectal cancer cells. Cell Biology International. PMID 31393067 DOI: 10.1002/Cbin.11215 |
0.49 |
|
| 2013 |
Jin Q, Gao G, Mulder KM. A dynein motor attachment complex regulates TGFß/Smad3 signaling. International Journal of Biological Sciences. 9: 531-40. PMID 23781147 DOI: 10.7150/Ijbs.5718 |
0.414 |
|
| 2013 |
Jin Q, Liu G, Domeier PP, Ding W, Mulder KM. Decreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells. Plos One. 8: e66439. PMID 23755307 DOI: 10.1371/Journal.Pone.0066439 |
0.474 |
|
| 2013 |
Jin Q, Zhong Y, Mulder KM. Requirement for protein kinase A in the phosphorylation of the TGFβ receptor-interacting protein km23-1 as a component of TGFβ downstream effects. Experimental Cell Research. 319: 897-907. PMID 23333499 DOI: 10.1016/J.Yexcr.2012.12.029 |
0.398 |
|
| 2013 |
Jin Q, Zhong Y, Mulder KM. Corrigendum to “Requirement for protein kinase A in the phosphorylation of the TGFβ receptor-interacting protein km23-1 as a component of TGFβ downstream effects” [Experimental Cell Research 319 (2013) 897–907] Experimental Cell Research. 319: 2307-2308. DOI: 10.1016/J.Yexcr.2013.06.001 |
0.349 |
|
| 2012 |
Jin Q, Pulipati NR, Zhou W, Staub CM, Liotta LA, Mulder KM. Role of km23-1 in RhoA/actin-based cell migration. Biochemical and Biophysical Research Communications. 428: 333-8. PMID 23079622 DOI: 10.1016/J.Bbrc.2012.10.047 |
0.351 |
|
| 2012 |
Jin Q, Ding W, Mulder KM. The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras. The Journal of Biological Chemistry. 287: 26453-63. PMID 22637579 DOI: 10.1074/Jbc.M112.344887 |
0.514 |
|
| 2012 |
Jin Q, Gao G, Mulder KM. Requirement of a dynein light chain in transforming growth factor β signaling in zebrafish ovarian follicle cells. Molecular and Cellular Endocrinology. 348: 233-40. PMID 21920407 DOI: 10.1016/J.Mce.2011.08.029 |
0.418 |
|
| 2012 |
Pandey MK, Liu G, Cooper TK, Mulder KM. Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice. International Journal of Cancer. 130: 213-22. PMID 21344377 DOI: 10.1002/Ijc.25997 |
0.36 |
|
| 2011 |
Pulipati NR, Jin Q, Liu X, Sun B, Pandey MK, Huber JP, Ding W, Mulder KM. Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase. International Journal of Cancer. 129: 553-64. PMID 21469138 DOI: 10.1002/Ijc.25954 |
0.434 |
|
| 2010 |
Mulder KM, Pulipati NR, Liu X, Sun B, Zhao Y, Jin Q, Ding W, Pandey MK, Huber JP. Growth control of human ovarian cancer cells by the dynein light chain and TGFβ receptor interacting protein km23-1 Clinical Cancer Research. 16. DOI: 10.1158/Diag-10-B31 |
0.468 |
|
| 2009 |
Jin Q, Gao G, Mulder KM. Requirement of a dynein light chain in TGFbeta/Smad3 signaling. Journal of Cellular Physiology. 221: 707-15. PMID 19711352 DOI: 10.1002/Jcp.21910 |
0.483 |
|
| 2007 |
Jin Q, Ding W, Mulder KM. Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway. The Journal of Biological Chemistry. 282: 19122-32. PMID 17420258 DOI: 10.1074/Jbc.M609915200 |
0.539 |
|
| 2006 |
Liu G, Ding W, Neiman J, Mulder KM. Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion. The Journal of Biological Chemistry. 281: 29479-90. PMID 16891311 DOI: 10.1074/Jbc.M600579200 |
0.593 |
|
| 2006 |
Liu G, Ding W, Liu X, Mulder KM. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells. Molecular Carcinogenesis. 45: 582-93. PMID 16637060 DOI: 10.1002/Mc.20189 |
0.409 |
|
| 2005 |
Ding W, Tang Q, Espina V, Liotta LA, Mauger DT, Mulder KM. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. Cancer Research. 65: 6526-33. PMID 16061631 DOI: 10.1158/0008-5472.Can-04-4385 |
0.508 |
|
| 2005 |
Jin Q, Ding W, Staub CM, Gao G, Tang Q, Mulder KM. Requirement of km23 for TGFbeta-mediated growth inhibition and induction of fibronectin expression. Cellular Signalling. 17: 1363-72. PMID 15925487 DOI: 10.1016/J.Cellsig.2005.02.004 |
0.487 |
|
| 2004 |
Ding W, Mulder KM. km23: a novel TGFbeta signaling target altered in ovarian cancer. Cancer Treatment and Research. 119: 315-27. PMID 15164884 DOI: 10.1007/1-4020-7847-1_15 |
0.354 |
|
| 2004 |
Yue J, Sun B, Liu G, Mulder KM. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. Journal of Cellular Physiology. 199: 284-92. PMID 15040011 DOI: 10.1002/Jcp.10469 |
0.73 |
|
| 2002 |
Tang Q, Staub CM, Gao G, Jin Q, Wang Z, Ding W, Aurigemma RE, Mulder KM. A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. Molecular Biology of the Cell. 13: 4484-96. PMID 12475967 DOI: 10.1091/Mbc.E02-05-0245 |
0.493 |
|
| 2001 |
Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacology & Therapeutics. 91: 1-34. PMID 11707292 DOI: 10.1016/S0163-7258(01)00143-7 |
0.732 |
|
| 2000 |
Yue J, Mulder KM. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway The Journal of Biological Chemistry. 275: 35656. PMID 11063751 |
0.717 |
|
| 2000 |
Yue J, Mulder KM. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. The Journal of Biological Chemistry. 275: 30765-73. PMID 10843986 DOI: 10.1074/Jbc.M000039200 |
0.743 |
|
| 2000 |
Yue J, Mulder KM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods in Molecular Biology (Clifton, N.J.). 142: 125-31. PMID 10806618 DOI: 10.1385/1-59259-053-5:125 |
0.714 |
|
| 2000 |
Mulder KM. Role of Ras and Mapks in TGFbeta signaling. Cytokine & Growth Factor Reviews. 11: 23-35. PMID 10708950 DOI: 10.1016/S1359-6101(99)00026-X |
0.572 |
|
| 1999 |
Yue J, Frey RS, Mulder KM. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene. 18: 2033-7. PMID 10208426 DOI: 10.1038/Sj.Onc.1202521 |
0.715 |
|
| 1999 |
Yue J, Hartsough MT, Frey RS, Frielle T, Mulder KM. Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway. Journal of Cellular Physiology. 178: 387-96. PMID 9989785 DOI: 10.1002/(Sici)1097-4652(199903)178:3<387::Aid-Jcp13>3.0.Co;2-8 |
0.711 |
|
| 1998 |
Liu X, Yue J, Frey RS, Zhu Q, Mulder KM. Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Cancer Research. 58: 4752-7. PMID 9788633 |
0.702 |
|
| 1998 |
Yue J, Buard A, Mulder KM. Blockade of TGFbeta3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells. Oncogene. 17: 47-55. PMID 9671313 DOI: 10.1038/Sj.Onc.1201903 |
0.717 |
|
| 1997 |
Hartsough MT, Mulder KM. Transforming growth factor-beta signaling in epithelial cells. Pharmacology & Therapeutics. 75: 21-41. PMID 9364579 DOI: 10.1016/S0163-7258(97)00020-X |
0.616 |
|
| 1997 |
Frey RS, Mulder KM. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Letters. 117: 41-50. PMID 9233830 DOI: 10.1016/S0304-3835(97)00211-5 |
0.512 |
|
| 1996 |
Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F, Mulder KM. Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. The Journal of Biological Chemistry. 271: 22368-75. PMID 8798398 DOI: 10.1074/Jbc.271.37.22368 |
0.594 |
|
| 1996 |
Buard A, Zipfel PA, Frey RS, Mulder KM. Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations. International Journal of Cancer. 67: 539-46. PMID 8759614 DOI: 10.1002/(Sici)1097-0215(19960807)67:4<539::Aid-Ijc13>3.0.Co;2-2 |
0.425 |
|
| 1995 |
Hartsough MT, Mulder KM. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. The Journal of Biological Chemistry. 270: 7117-24. PMID 7706248 DOI: 10.1074/Jbc.270.13.7117 |
0.581 |
|
| 1995 |
Zhou GHK, Sechrist GL, Brattain MG, Mulder KM. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGFβ isoforms Journal of Cellular Physiology. 165: 512-520. PMID 7593230 DOI: 10.1002/Jcp.1041650309 |
0.359 |
|
| 1993 |
Mulder KM, Segarini PR, Morris SL, Ziman JM, Choi HG. Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clones. Journal of Cellular Physiology. 154: 162-74. PMID 8380421 DOI: 10.1002/Jcp.1041540120 |
0.507 |
|
| 1993 |
Brattain MG, Mulder KM, Wu SP, Howell G, Sun L, Willson JKV, Ziober BL. Altered Expression of Transforming Growth Factor-α and Transforming Growth Factor-β Autocrine Loops in Cancer Cells Advances in Molecular and Cell Biology. 7: 35-59. DOI: 10.1016/S1569-2558(08)60234-9 |
0.305 |
|
| 1992 |
Wu S, Theodorescu D, Kerbel RS, Willson JKV, Mulder KM, Humphrey LE, Brattain MG. TGF-βi is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector Journal of Cell Biology. 116: 187-196. PMID 1730743 DOI: 10.1083/Jcb.116.1.187 |
0.44 |
|
| 1990 |
Mulder KM, Humphrey LE, Choi HG, Childress-Fields KE, Brattain MG. Evidence for c-myc in the signaling pathway for TGF-β in well-differentiated human colon carcinoma cells Journal of Cellular Physiology. 145: 501-507. PMID 2273056 DOI: 10.1002/Jcp.1041450316 |
0.445 |
|
| 1990 |
Mulder KM, Childress-Fields KE. Characterization of a serum-free culture system comparing growth factor requirements of transformed and untransformed cells. Experimental Cell Research. 188: 254-61. PMID 2185944 DOI: 10.1016/0014-4827(90)90167-9 |
0.451 |
|
| 1989 |
Mulder KM, Brattain MG. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells Molecular Endocrinology. 3: 1215-1222. PMID 2674694 DOI: 10.1210/Mend-3-8-1215 |
0.417 |
|
| 1989 |
Mulder KM, Brattain MG. Continous maintenance of transformed fibroblasts under reduced serum conditions: Utility as a model system for investigating growth factor-specific effects in nonquiescent cells Journal of Cellular Physiology. 138: 450-458. PMID 2647770 DOI: 10.1002/Jcp.1041380303 |
0.448 |
|
| 1989 |
Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1 Experimental Cell Research. 181: 442-453. PMID 2538337 DOI: 10.1016/0014-4827(89)90101-8 |
0.398 |
|
| 1988 |
Mulder KM, Brattain MG. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells International Journal of Cancer. 42: 64-70. PMID 3164710 DOI: 10.1002/Ijc.2910420113 |
0.44 |
|
| 1988 |
Mulder KM, Levine AE, Hernandez X, McKnight MK, Brattain DE, Brattain MG. Modulation of C-myc by transforming growth factor-β in human colon carcinoma cells Biochemical and Biophysical Research Communications. 150: 711-716. PMID 2893611 DOI: 10.1016/0006-291X(88)90449-4 |
0.433 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2005 |
Ilangovan U, Ding W, Zhong Y, Wilson CL, Groppe JC, Trbovich JT, Zúñiga J, Demeler B, Tang Q, Gao G, Mulder KM, Hinck AP. Structure and dynamics of the homodimeric dynein light chain km23. Journal of Molecular Biology. 352: 338-54. PMID 16083906 DOI: 10.1016/J.Jmb.2005.07.002 |
0.268 |
|
| 1981 |
Roth JA, Eddy BJ, Pearce LB, Mulder KM. Phenylhydrazine: Selective inhibition of human brain type B monoamine oxidase Biochemical Pharmacology. 30: 945-950. PMID 7236315 DOI: 10.1016/0006-2952(81)90038-1 |
0.251 |
|
| 1985 |
Mulder KM, Kostyniak PJ. Involvement of glutathione in the enhanced renal excretion of methyl mercury in CFW Swiss mice. Toxicology and Applied Pharmacology. 78: 451-7. PMID 2864752 DOI: 10.1016/0041-008X(85)90252-2 |
0.205 |
|
| 1985 |
Mulder KM, Kostyniak PJ. Stabilization of glutathione in urine and plasma: relevance to urinary metal excretion studies. Journal of Analytical Toxicology. 9: 31-5. PMID 2858603 DOI: 10.1093/Jat/9.1.31 |
0.201 |
|
| Hide low-probability matches. |